399 related articles for article (PubMed ID: 27693645)
1. Comparing 3 guidelines on the management of surgically removed pancreatic cysts with regard to pathological outcome.
Lekkerkerker SJ; Besselink MG; Busch OR; Verheij J; Engelbrecht MR; Rauws EA; Fockens P; van Hooft JE
Gastrointest Endosc; 2017 May; 85(5):1025-1031. PubMed ID: 27693645
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of the AGA, IAP, and European guidelines for detecting advanced neoplasia in intraductal papillary mucinous neoplasm/neoplasia.
van Huijgevoort NCM; Hoogenboom SAM; Lekkerkerker SJ; Busch OR; Del Chiaro M; Fockens P; Somers I; Verheij J; Voermans RP; Besselink MG; van Hooft JE
Pancreatology; 2023 Apr; 23(3):251-257. PubMed ID: 36805049
[TBL] [Abstract][Full Text] [Related]
3. American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data.
Singhi AD; Zeh HJ; Brand RE; Nikiforova MN; Chennat JS; Fasanella KE; Khalid A; Papachristou GI; Slivka A; Hogg M; Lee KK; Tsung A; Zureikat AH; McGrath K
Gastrointest Endosc; 2016 Jun; 83(6):1107-1117.e2. PubMed ID: 26709110
[TBL] [Abstract][Full Text] [Related]
4. The validity of the surgical indication for intraductal papillary mucinous neoplasm of the pancreas advocated by the 2017 revised International Association of Pancreatology consensus guidelines.
Watanabe Y; Endo S; Nishihara K; Ueda K; Mine M; Tamiya S; Nakano T; Tanaka M
Surg Today; 2018 Nov; 48(11):1011-1019. PubMed ID: 29961172
[TBL] [Abstract][Full Text] [Related]
5. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
6. High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound.
Wong J; Weber J; Centeno BA; Vignesh S; Harris CL; Klapman JB; Hodul P
J Gastrointest Surg; 2013 Jan; 17(1):78-84; discussion p.84-5. PubMed ID: 22948841
[TBL] [Abstract][Full Text] [Related]
7. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.
Rezaee N; Barbon C; Zaki A; He J; Salman B; Hruban RH; Cameron JL; Herman JM; Ahuja N; Lennon AM; Weiss MJ; Wood LD; Wolfgang CL
HPB (Oxford); 2016 Mar; 18(3):236-46. PubMed ID: 27017163
[TBL] [Abstract][Full Text] [Related]
8. Fukuoka and AGA Criteria Have Superior Diagnostic Accuracy for Advanced Cystic Neoplasms than Sendai Criteria.
Sighinolfi M; Quan SY; Lee Y; Ibaseta A; Pham K; Dua MM; Poultsides GA; Visser BC; Norton JA; Park WG
Dig Dis Sci; 2017 Mar; 62(3):626-632. PubMed ID: 28116593
[TBL] [Abstract][Full Text] [Related]
9. Synchronous pancreatic solid pseudopapillary neoplasm and intraductal papillary mucinous neoplasm.
Hirabayashi K; Zamboni G; Ito H; Ogawa M; Kawaguchi Y; Yamashita T; Nakagohri T; Nakamura N
World J Gastroenterol; 2013 Jun; 19(21):3358-63. PubMed ID: 23745041
[TBL] [Abstract][Full Text] [Related]
10. Clinical approach to incidental pancreatic cysts.
Chiang AL; Lee LS
World J Gastroenterol; 2016 Jan; 22(3):1236-45. PubMed ID: 26811661
[TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment of benign, premalignant and low-risk tumors of the pancreas : Standard resection or parenchyma preserving, local extirpation].
Beger HG
Chirurg; 2016 Jul; 87(7):579-84. PubMed ID: 26943167
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of neoplastic pancreatic cysts without high-risk stigmata: how often do we change treatment strategy because of malignant transformation?
Lekkerkerker SJ; Besselink MG; Busch OR; Dijk F; Engelbrecht MR; Rauws EA; Fockens P; van Hooft JE
Scand J Gastroenterol; 2016 Sep; 51(9):1138-43. PubMed ID: 27175891
[TBL] [Abstract][Full Text] [Related]
13. Cystic lesions and intraductal neoplasms of the pancreas.
Fasanella KE; McGrath K
Best Pract Res Clin Gastroenterol; 2009; 23(1):35-48. PubMed ID: 19258185
[TBL] [Abstract][Full Text] [Related]
14. Cytologic categorization of pancreatic neoplastic mucinous cysts with an assessment of the risk of malignancy: A retrospective study based on the Papanicolaou Society of Cytopathology guidelines.
Smith AL; Abdul-Karim FW; Goyal A
Cancer Cytopathol; 2016 Apr; 124(4):285-93. PubMed ID: 26618476
[TBL] [Abstract][Full Text] [Related]
15. Duodenum and ventral pancreas preserving subtotal pancreatectomy for low-grade malignant neoplasms of the pancreas: An alternative procedure to total pancreatectomy for low-grade pancreatic neoplasms.
Wang X; Tan CL; Song HY; Yao Q; Liu XB
World J Gastroenterol; 2017 Sep; 23(35):6457-6466. PubMed ID: 29085195
[TBL] [Abstract][Full Text] [Related]
16. Patterns of recurrence and long-term outcomes in patients who underwent pancreatectomy for intraductal papillary mucinous neoplasms with high grade dysplasia: implications for surveillance and future management guidelines.
Blackham AU; Doepker MP; Centeno BA; Springett G; Pimiento JM; Malafa M; Hodul PJ
HPB (Oxford); 2017 Jul; 19(7):603-610. PubMed ID: 28495434
[TBL] [Abstract][Full Text] [Related]
17. Cross Validation of the Monoclonal Antibody Das-1 in Identification of High-Risk Mucinous Pancreatic Cystic Lesions.
Das KK; Geng X; Brown JW; Morales-Oyarvide V; Huynh T; Pergolini I; Pitman MB; Ferrone C; Al Efishat M; Haviland D; Thompson E; Wolfgang C; Lennon AM; Allen P; Lillemoe KD; Fields RC; Hawkins WG; Liu J; Castillo CF; Das KM; Mino-Kenudson M
Gastroenterology; 2019 Sep; 157(3):720-730.e2. PubMed ID: 31175863
[TBL] [Abstract][Full Text] [Related]
18. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.
Sahora K; Mino-Kenudson M; Brugge W; Thayer SP; Ferrone CR; Sahani D; Pitman MB; Warshaw AL; Lillemoe KD; Fernandez-del Castillo CF
Ann Surg; 2013 Sep; 258(3):466-75. PubMed ID: 24022439
[TBL] [Abstract][Full Text] [Related]
19. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the diagnostic accuracy of three current guidelines for the evaluation of asymptomatic pancreatic cystic neoplasms.
Xu MM; Yin S; Siddiqui AA; Salem RR; Schrope B; Sethi A; Poneros JM; Gress FG; Genkinger JM; Do C; Brooks CA; Chabot JA; Kluger MD; Kowalski T; Loren DE; Aslanian H; Farrell JJ; Gonda TA
Medicine (Baltimore); 2017 Sep; 96(35):e7900. PubMed ID: 28858107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
